NCT01884415View on ClinicalTrials.gov

Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis

PHASE3CompletedINTERVENTIONAL

Enrollment

112

Participants

Timeline

Start Date

September 7, 2012

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

Hepatitis BCirrhosisAwaiting Organ Transplant

Interventions

BIOLOGICAL

HBV vaccine

Patients receive a second cycle of vaccination

BIOLOGICAL

HBV vaccine

Patients receive vaccination according to the guidelines.

Trial Locations (1)

41013

Virgen del Rocío Hospital, Seville

All Listed Sponsors

lead

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER

NCT01884415 - Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis | Biotech Hunter | Biotech Hunter